View in EDS

Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction.

Saved in:
Bibliographic Details
Title: Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction.
Authors: Vaccaro K; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA., Allen J; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA., Whitfield TW; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA., Maoz A; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA.; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Reeves S; Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA., Velarde J; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA., Yang D; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA., Meglan A; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA., Ribeiro J; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA., Blandin J; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA., Phan N; Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA., Bell GW; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA., Hata AN; Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA.; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA., Weiskopf K; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA.; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Source: The Journal of clinical investigation [J Clin Invest] 2024 Mar 14; Vol. 134 (9). Date of Electronic Publication: 2024 Mar 14.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38483480
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Vaccaro+K%22">Vaccaro K</searchLink>; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Allen+J%22">Allen J</searchLink>; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Whitfield+TW%22">Whitfield TW</searchLink>; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Maoz+A%22">Maoz A</searchLink>; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA.; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Reeves+S%22">Reeves S</searchLink>; Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Velarde+J%22">Velarde J</searchLink>; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Yang+D%22">Yang D</searchLink>; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Meglan+A%22">Meglan A</searchLink>; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Ribeiro+J%22">Ribeiro J</searchLink>; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Blandin+J%22">Blandin J</searchLink>; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Phan+N%22">Phan N</searchLink>; Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Bell+GW%22">Bell GW</searchLink>; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Hata+AN%22">Hata AN</searchLink>; Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA.; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Weiskopf+K%22">Weiskopf K</searchLink>; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA.; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227802877%22">The Journal of clinical investigation</searchLink> [J Clin Invest] 2024 Mar 14; Vol. 134 (9). <i>Date of Electronic Publication: </i>2024 Mar 14.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+for+Clinical+Investigation%22">American Society for Clinical Investigation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7802877 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1558-8238 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200219738%22">00219738 </searchLink><i>NLM ISO Abbreviation: </i>J Clin Invest <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38483480
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1172/JCI169315
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Vaccaro K
      – PersonEntity:
          Name:
            NameFull: Allen J
      – PersonEntity:
          Name:
            NameFull: Whitfield TW
      – PersonEntity:
          Name:
            NameFull: Maoz A
      – PersonEntity:
          Name:
            NameFull: Reeves S
      – PersonEntity:
          Name:
            NameFull: Velarde J
      – PersonEntity:
          Name:
            NameFull: Yang D
      – PersonEntity:
          Name:
            NameFull: Meglan A
      – PersonEntity:
          Name:
            NameFull: Ribeiro J
      – PersonEntity:
          Name:
            NameFull: Blandin J
      – PersonEntity:
          Name:
            NameFull: Phan N
      – PersonEntity:
          Name:
            NameFull: Bell GW
      – PersonEntity:
          Name:
            NameFull: Hata AN
      – PersonEntity:
          Name:
            NameFull: Weiskopf K
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 14
              M: 03
              Text: 2024 Mar 14
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1558-8238
          Numbering:
            – Type: volume
              Value: 134
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: The Journal of clinical investigation
              Type: main
ResultId 1